Commit To Buy Rhythm Pharmaceuticals At $7.50, Earn 14.2% Annualized Using Options
August 20, 2021 at 11:43 AM EDT
Investors considering a purchase of Rhythm Pharmaceuticals Inc (RYTM) shares, but tentative about paying the going market price of $11.80/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2022 put at the $7.50 strike, which has a bid at the time of this writing of 45 cents..